A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
Clinical trial NCT00978016 · COMPLETED
Trial details
- NCT number
- NCT00978016
- Sponsor
- XenoPort, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-12-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.